|
業務類別
|
Medical Instruments & Supplies |
|
業務概覽
|
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space. |
| 公司地址
| 520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4 |
| 電話號碼
| +1 905 695-7700 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.bausch.com |
| 員工數量
| 13000 |
| Mr. Brenton L. Saunders |
Chief Executive Officer and Chairman of the Board |
美元 1.60M |
18/02/2026 |
| Mr. Andrew J. Stewart |
President, Global Pharmaceuticals and International Consumer |
美元 616.27K |
10/04/2025 |
| Mr. A. Robert D. Bailey |
Executive Vice President and Chief Legal Officer |
美元 767.42K |
10/04/2025 |
| Mr. Frederick J. Munsch |
Senior Vice President, Controller and Chief Accounting Officer |
-- |
18/02/2026 |
| Mr. Luc Bonnefoy |
President, Surgical |
-- |
10/04/2025 |
| Mr. Sam A. Eldessouky |
Chief Financial Officer and Executive Vice President |
美元 766.89K |
18/02/2026 |
| Dr. Yehia Hashad, M.D. |
Executive Vice President, Research and Development and Chief Medical Officer |
美元 696.85K |
10/04/2025 |
|
|
| Mr. Brenton L. Saunders |
Chief Executive Officer and Chairman of the Board |
18/02/2026 |
| Mr. Steven H. Collis |
Director |
18/02/2026 |
| Ms. Karen L. Ling |
Independent Director |
18/02/2026 |
| Mr. Russel C. Robertson |
Independent Director |
18/02/2026 |
| Dr. Andrew C. von Eschenbach, M.D. |
Independent Director |
18/02/2026 |
| Ms. Sarah B. Kavanagh |
Independent Director |
18/02/2026 |
| Mr. Thomas W. Ross, Sr |
Lead Independent Director |
18/02/2026 |
| Mr. John A. Paulson |
Independent Director |
18/02/2026 |
| Ms. Nathalie Bernier, F.C.A. |
Independent Director |
18/02/2026 |
| Mr. Eduardo C. Alfonso |
Director |
18/02/2026 |
|
|
|
|
